SELGENE selegiline hydrochloride 5mg tablet blister pack Australia - inglese - Department of Health (Therapeutic Goods Administration)

selgene selegiline hydrochloride 5mg tablet blister pack

alphapharm pty ltd - selegiline hydrochloride, quantity: 5 mg - tablet, uncoated - excipient ingredients: citric acid monohydrate; purified talc; maize starch; magnesium stearate; povidone; lactose monohydrate - may be of benefit as an adjunct in the management of late stage parkinson's disease in patients being treated with levodopa with/without a peripheral decarboxylase inhibitor, who exhibit deterioration in the quality of their response of therapy. indications as at 1 december 1999: treatment of patients with parkinson's disease. it can be used as monotherapy in the early phases of the disease and as adjunctive therapy with levodopa (with/without a peripheral decarboxylase inhibitor).

Selegiline 5mg tablets Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

selegiline 5mg tablets

a a h pharmaceuticals ltd - selegiline hydrochloride - oral tablet - 5mg

Selegiline 5mg tablets Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

selegiline 5mg tablets

ivax pharmaceuticals uk ltd - selegiline hydrochloride - oral tablet - 5mg

Selegiline 5mg tablets Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

selegiline 5mg tablets

alliance healthcare (distribution) ltd - selegiline hydrochloride - oral tablet - 5mg